These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3052064)

  • 1. A controlled trial of stimulant medication in children with the fragile X syndrome.
    Hagerman RJ; Murphy MA; Wittenberger MD
    Am J Med Genet; 1988; 30(1-2):377-92. PubMed ID: 3052064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.
    Arnold LE; Christopher J; Huestis R; Smeltzer DJ
    Arch Gen Psychiatry; 1978 Apr; 35(4):463-73. PubMed ID: 365123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G
    Am J Med Genet A; 2008 Apr; 146A(7):803-12. PubMed ID: 18286595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?
    Elia J; Borcherding BG; Rapoport JL; Keysor CS
    Psychiatry Res; 1991 Feb; 36(2):141-55. PubMed ID: 2017529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of stimulant medication on academic performance, in the context of multimodal treatment, in attention deficit disorders with hyperactivity: two case reports.
    Schmidt K; Solanto MV; Sanchez-Kappraff M; Vargas P; Wein S
    J Clin Psychopharmacol; 1984 Apr; 4(2):100-3. PubMed ID: 6707235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of stimulants on electrodermal studies in Fragile X syndrome.
    Hagerman RJ; Miller LJ; McGrath-Clarke J; Riley K; Goldson E; Harris SW; Simon J; Church K; Bonnell J; Ognibene TC; McIntosh DN
    Microsc Res Tech; 2002 May; 57(3):168-73. PubMed ID: 12112453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classroom academic performance: improvement with both methylphenidate and dextroamphetamine in ADHD boys.
    Elia J; Welsh PA; Gullotta CS; Rapoport JL
    J Child Psychol Psychiatry; 1993 Jul; 34(5):785-804. PubMed ID: 8340445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid as an adjunct in the treatment of children with the autism fragile-X syndrome (AFRAX).
    Gillberg C; Wahlström J; Johansson R; Törnblom M; Albertsson-Wikland K
    Dev Med Child Neurol; 1986 Oct; 28(5):624-7. PubMed ID: 3536640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ADDH in mentally retarded children: a preliminary study.
    Payton JB; Burkhart JE; Hersen M; Helsel WJ
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):761-7. PubMed ID: 2676965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant drug treatment of hyperactivity: biochemical correlates.
    Elia J; Borcherding BG; Potter WZ; Mefford IN; Rapoport JL; Keysor CS
    Clin Pharmacol Ther; 1990 Jul; 48(1):57-66. PubMed ID: 2196146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
    Efron D; Jarman F; Barker M
    Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral folic acid versus placebo in the treatment of males with the fragile X syndrome.
    Hagerman RJ; Jackson AW; Levitas A; Braden M; McBogg P; Kemper M; McGavran L; Berry R; Matus I; Hagerman PJ
    Am J Med Genet; 1986; 23(1-2):241-62. PubMed ID: 3513567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid treatment in males and females with fragile-(X)-syndrome.
    Froster-Iskenius U; Bödeker K; Oepen T; Matthes R; Piper U; Schwinger E
    Am J Med Genet; 1986; 23(1-2):273-89. PubMed ID: 3513569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled study of folic acid treatment in three fragile X syndrome males.
    Madison LS; Wells TE; Fristo TE; Benesch CG
    J Dev Behav Pediatr; 1986 Aug; 7(4):253-6. PubMed ID: 3528223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE; Gadow KD; Sprafkin J
    Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD; Wolraich ML
    Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.